Effects of soy phytoestrogens on pituitary-ovarian function in middle-aged female rats
- 247 Downloads
The aim of this study was to assess the effects of genistein (G) and daidzein (D) on the histological, hormonal, and functional parameters of the pituitary-ovarian axis in middle-aged female rats, and to compare these effects with the effects of estradiol (E), commonly used in the prevention and treatment of menopausal symptoms. Middle-aged (12 month old) Wistar female rats subcutaneously received 35 mg/kg of G, or 35 mg/kg of D, or 0.625 mg/kg of E every day for 4 weeks. Each of the treated groups had a corresponding control group. An intact control group was also established. G and D did not change the intracellular protein content within gonadotropic and lactotropic cells, but vacuolization was observed in all the cell types. In contrast, E caused an inhibition of gonadotropic and stimulation of lactotropic cells. Also, ovaries of middle-aged female rats exposed to G or D have more healthy primordial and primary follicles and less atretic follicles. E treatment in the ovaries had a mostly negative effect, which is reflected by the increased number of atretic follicles in all tested classes. G and D provoked decrease in CuZnSOD and CAT activity, while E treatment increased MnSOD and decreased CuZnSOD and GSHPx activity. All the treatments increased serum estradiol and decreased testosterone levels, while D and E increased the serum progesterone level. In conclusion, soy phytoestrogens exhibited beneficial effects on pituitary-ovarian function in middle-aged female rats, as compared to estradiol.
KeywordsGenistein Daidzein Estradiol Pituitary-ovarian function
This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia, Grant Number 173009. The authors wish to express their sincere gratitude to Olympus d.o.o. Belgrade, Serbia, for technical support.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 4.J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, J. Ockene, Writing Group for the Women’s Health Initiative Investigators, Risks and benefits of estrogen plus progestin in healthy postmenopausal women, principal results. From the Women’s Health Initiative randomized controlled trial. JAMA 288, 321–333 (2002)CrossRefPubMedGoogle Scholar
- 6.J.E. Manson, R.T. Chlebowski, M.L. Stefanick, A.K. Aragaki, J.E. Rossouw, Anderson G. PrenticeRL, B.V. Howard, C.A. Thomson, A.Z. LaCroix, J. Wactawski-Wende, R.D. Jackson, M. Limacher, K.L. Margolis, S. Wassertheil-Smoller, S.A. Beresford, J.A. Cauley, C.B. Eaton, M. Gass, J. Hsia, K.C. Johnson, C. Kooperberg, L.H. Kuller, C.E. Lewis, S. Liu, L.W. Martin, J.K. Ockene, M.J. O’Sullivan, L.H. Powell, M.S. Simon et al., Menopausal hormone therapy and health outcomes during theintervention and extended poststopping phases of the Women’s HealthInitiative randomized trials. JAMA 310, 1353–1368 (2013)CrossRefPubMedGoogle Scholar
- 18.J. Hsia, R.D. Langer, J.E. Manson, L. Kuller, K.C. Johnson, S.L. Hendrix, M. Pettinger, S.R. Heckbert, N. Greep, S. Crawford, C.B. Eaton, J.B. Kostis, P. Caralis, R. Prentice, Conjugated equine estrogens and coronary heart disease: the Women’s Health Initiative. Women’s Health Initiative Investigators. Arch. Intern. Med. 166, 357–365 (2006)CrossRefPubMedGoogle Scholar
- 30.M. Manojlović-Stojanoski, N. Nestorović, N. Ristić, S. Trifunović, B. Filipović, B. Šošić-Jurjević, M. Sekulić, Unbiased stereological estimation of the rat fetal pituitary volume and of the total number and volume of TSH cells after maternal dexamethasone application. Microsc. Res. Tech. 73, 1077–1085 (2010)CrossRefPubMedGoogle Scholar
- 32.A. Claiborne, Assay for catalase in handbook of methods for oxygen radical research (CRC Press, Boca Raton, 1985), pp. 283–284Google Scholar
- 33.D.E. Paglia, W.N. Valentine, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70, 74–77 (1967)Google Scholar
- 39.Y. Liu, L. Hilakivi-Clarke, Y. Zhang, X. Wang, Y.X. Pan, J. Xuan, S.C. Fleck, D.R. Doerge, W.G. Helferich, Isoflavones in soy flour diet have different effects on whole-genome expression patterns than purified isoflavone mix in human MCF-7 breast tumors in ovariectomized athymic nude mice. Mol. Nutr. Food Res. (2015). doi:10.1002/mnfr.201500028 PubMedCentralGoogle Scholar
- 48.M. Yamasaki, S. Fujita, E. Ishiyama, A. Mukai, H. Madhyastha, Y. Sakakibara, M. Suiko, K. Hatakeyama, T. Nemoto, K. Morishita, H. Kataoka, H. Tsubouchi, K. Nishiyama, Soy-derived isoflavones inhibit the growth of adult T-cell leukemia cells in vitro and in vivo. Cancer Sci. 98, 1740–1746 (2007)CrossRefPubMedGoogle Scholar